Adari Cell Science, in partnership with ReadyCell (Barcelona), aims to advance the field of drug discovery by providing cutting-edge, ready-to-use cell-based assays to companies and institutions across Canada and the United States.
Our innovative solutions empower scientists and researchers to accelerate their drug development process, leading to breakthroughs in medical science and the discovery of life-changing treatments.
Our comprehensive range of ready-to-use kits for transporters is designed to streamline your drug discovery process. Further, our tools are innovative cell-based and ready-to-use kits for efficacy and safety testing of active molecules as an alternative to animal testing for drug discovery.
Readycell’s patented shipping medium, a gel-like preservation matrix, allows for our cell-based assays to be shipped at room temperature with excellent stability.
At AdariCell, we prioritize quality and performance in every aspect of our assays. Each kit undergoes rigorous testing to guarantee accuracy, sensitivity, and specificity to ensure they comply with ISO9001. We also adhere to strict quality control measures to ensure that our cell-based assays exceed industry standards.
Our dedicated team of experts is available to assist you with any inquiries, technical support, or troubleshooting needs. We value your research goals and strive to provide the guidance and assistance necessary to propel your drug discovery journey forward.
The MDR1 efflux transporter has a ubiquitous tissue distribution, with a critical role in intestinal absorption, biliary and urinary excretion of drugs and the entry of active molecules into the central nervous system.
24 or 96 transwell insert plates cultured with 12 days differentiated BCRP-overexpressing MDCKII cells. BCRP is a high-capacity efflux transporter with broad substrate specificity.
Ready to accelerate your research and make a meaningful impact? Explore our range of ready-to-use kits and discover the tools you need to unlock the potential of drug discovery.